Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
An earlier Phase 2 trial in adults with type 2 diabetes and obesity showed bimagrumab produced significant reductions in fat mass with simultaneous increases in lean mass compared to placebo over 48 weeks
The physician-directed clinical team reviews this information before any infusion formula is ordered, ensuring the protocol is both safe and appropriate for the individual
A comprehensive strategy accounts for medical history, lifestyle, and long-term sustainability
FDA-approved Rybelsus or Ozempic represent valuable options for managing type 2 diabetes, offering tailored solutions to meet a personal preference and goal
Wang MH, Friton JJ, Rebert N, Monroe K, Nix BD, Fiocchi C, et al
US$ 20.05
US$ 21.73
US$ 29.08
US$ 28.45
.jpg)
